• Products
  • Community
  • Markets
  • Brokers
  • More
Get started
  • News
  • /奥锐特:已完成司美格鲁肽原料药产品中试
GelonghuiGelonghui

奥锐特:已完成司美格鲁肽原料药产品中试

605116

格隆汇8月10日丨奥锐特在互动平台表示,公司目前已完成司美格鲁肽原料药的产品中试。司美格鲁肽生产线目前还在建设中。

Read more from Gelonghui

605116 chart

Analyze on Supercharts

Latest news

Live

More news from Gelonghui


Select market data provided by ICE Data services. Select reference data provided by FactSet. Copyright © 2025 FactSet Research Systems Inc.© 2025 TradingView, Inc.

More than a product
  • Supercharts
Screeners
  • Stocks
  • ETFs
  • Bonds
  • Crypto coins
  • CEX pairs
  • DEX pairs
  • Pine
Heatmaps
  • Stocks
  • ETFs
  • Crypto
Calendars
  • Economic
  • Earnings
  • Dividends
More products
  • Yield Curves
  • Options
  • News Flow
  • Pine Script®
Apps
  • Mobile
  • Desktop
Community
  • Social network
  • Wall of Love
  • Refer a friend
  • House Rules
  • Moderators
Ideas
  • Trading
  • Education
  • Editors' picks
Pine Script
  • Indicators & strategies
  • Wizards
  • Freelancers
Tools & subscriptions
  • Features
  • Pricing
  • Market data
Trading
  • Overview
  • Brokers
Special offers
  • CME Group futures
  • Eurex futures
  • US stocks bundle
About company
  • Who we are
  • Space mission
  • Blog
  • Careers
  • Media kit
Merch
  • TradingView store
  • Tarot cards for traders
  • The C63 TradeTime
Policies & security
  • Terms of Use
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Accessibility Statement
  • Security tips
  • Bug Bounty program
  • Status page
Business solutions
  • Widgets
  • Charting libraries
  • Lightweight Charts™
  • Advanced Charts
  • Trading Platform
Growth opportunities
  • Advertising
  • Brokerage integration
  • Partner program
  • Education program
Community
  • Social network
  • Wall of Love
  • Refer a friend
  • House Rules
  • Moderators
Ideas
  • Trading
  • Education
  • Editors' picks
Pine Script
  • Indicators & strategies
  • Wizards
  • Freelancers
Business solutions
  • Widgets
  • Charting libraries
  • Lightweight Charts™
  • Advanced Charts
  • Trading Platform
Growth opportunities
  • Advertising
  • Brokerage integration
  • Partner program
  • Education program
Look FirstLook First